Immune-suppressive properties of the tumor microenvironment.
about
Metabolomics in rheumatic diseases: desperately seeking biomarkersInterleukin 12: still a promising candidate for tumor immunotherapy?Improving cancer immunotherapy by targeting the STATe of MDSCsDissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.Rapid and efficient transfer of the T cell aging marker CD57 from glioblastoma stem cells to CAR T cellsVaccines for cancer prevention: a practical and feasible approach to the cancer epidemic.Potential therapeutic effect of the secretome from human uterine cervical stem cells against both cancer and stromal cells compared with adipose tissue stem cells.Randomized controlled phase III trial of adjuvant chemo-immunotherapy with activated killer T cells and dendritic cells in patients with resected primary lung cancer.High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancerDendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by PlasminPre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes.The role of tumor-associated macrophages in breast carcinoma invasion and metastasis.Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in MiceA matrix metalloproteinase inhibitor enhances anti-cytotoxic T lymphocyte antigen-4 antibody immunotherapy in breast cancer by reprogramming the tumor microenvironmentRetroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-Fluorouracil-Mediated Cytotoxicity in Multiple Human Cancer Types.Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumorsRegional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic deliveryProfiling the dynamic expression of checkpoint molecules on cytokine-induced killer cells from non-small-cell lung cancer patients.Circulating MMP11 and specific antibody immune response in breast and prostate cancer patientsHigh expression of ecto-nucleotidases CD39 and CD73 in human endometrial tumors.Obstructive sleep apnea and cancer: Epidemiologic links and theoretical biological constructs.The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response.Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?Metabolism of stromal and immune cells in health and disease.Emerging strategies for cancer immunoprevention.Not just for tumor targeting: unmet medical needs and opportunities for nanomedicine.Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities.Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer.T-cell responses to oncogenic merkel cell polyomavirus proteins distinguish patients with merkel cell carcinoma from healthy donors.Patient-derived glioblastoma stem cells are killed by CD133-specific CAR T cells but induce the T cell aging marker CD57.Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.Arginine-Dual roles as an onconutrient and immunonutrient.Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.Modern strategies and capabilities for activation of the immune response against tumor cells.The interplay between metabolic remodeling and immune regulation in glioblastoma.Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis.Targetless T cells in cancer immunotherapy.
P2860
Q26765005-0C344A84-056E-4D34-98BA-2016234A2573Q26861559-B0BCE137-2F27-48B8-9399-F0F55DDB2590Q28066797-1004E974-A4FC-4158-BB36-ECB6E9E9658AQ34041661-65B948DB-471F-4160-8B0E-527DACD08E5EQ34044302-497D1708-0FBF-44D8-9D20-43E09093F39FQ34180316-EBBE78ED-1B50-4752-B93B-36E7317C5236Q34786543-C0499FD3-777D-45DD-85A0-8335B9CF8EC3Q34807804-461E9DC9-CD3F-4658-B82C-FEE29B7EA0BFQ35010242-F0C7EF66-7AC0-44E5-9C51-B3EB2712C232Q35680210-1C185490-39D4-4737-A667-508E87BA3536Q35692171-EDB53F0F-7513-4F44-8129-7FB03851F410Q35919089-84BDA85F-8108-4167-A9E9-C733A52A7F27Q36249314-4A48076D-9656-46F5-9875-AE223F1297B3Q36572163-51132C31-566B-4C7D-BCC5-C1F7010D630AQ36602123-F26358A7-D997-4474-9855-3906D20347E9Q36757056-E35E3F04-94C6-4090-B88E-EFF0A644C28CQ37268993-2C11FE90-941E-4DF6-A688-92341E0897DDQ37497357-9B08B2F4-455B-4D2B-9D0A-DC64544CC258Q37536649-8894F5E8-B8B0-4323-9EDD-61C887AD9D08Q37607101-F562553C-E4B0-4631-8E16-BE62EEC76977Q37636282-94D40550-E94B-4A4D-857C-E6208F73E97DQ37731479-0BC7C459-8919-4F49-9C5A-071CB0AAC6DDQ37745399-046EC6B2-031C-499D-A038-A376D2D03916Q38193822-2D470B8B-A75A-43A5-BAE1-AB8DC9044DBAQ38227775-4EDFA601-B58F-41C6-9F04-DC42683A2157Q38585850-198050F9-BD39-42A6-85E6-8F1767C5F5EBQ38602136-E68367F7-2FA3-4F77-8032-7EB21D5C113DQ38608414-EAF766EF-A9C6-4374-B206-4F29A2758999Q38682486-0BE48091-E6F3-4DE2-8511-4937D098B402Q38767892-F5C2F6D2-7F9D-4DF9-9911-1F80BBB227B2Q38848404-2FD79F1C-0BAA-40F6-86A0-B4D7CFECA2DBQ38871209-C5966591-0E55-4B9E-A7E8-1D607E160AAFQ38937646-0620AA5F-B286-4A18-B6E8-23C4FA02AFBBQ38988078-70BAAB8E-0C99-482B-9057-446148E1CD57Q39012828-96D97F77-9137-4361-A3DC-B5CBBB59E614Q39178061-7DB150F9-77AE-4529-A3DD-C9C9AA7A0D63Q39312666-DB4207C0-5E3D-4560-91E8-F132E86AAEEAQ39328710-63D07C8B-6E1B-45D1-859C-DD31D911D22BQ39343327-FD18E0FB-5F44-49CD-B6BA-5264122541F9Q40322821-8A6C3CA1-A1A8-42D7-9967-240F17B276A1
P2860
Immune-suppressive properties of the tumor microenvironment.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Immune-suppressive properties of the tumor microenvironment.
@en
type
label
Immune-suppressive properties of the tumor microenvironment.
@en
prefLabel
Immune-suppressive properties of the tumor microenvironment.
@en
P2860
P1476
Immune-suppressive properties of the tumor microenvironment.
@en
P2093
David Schrama
Jürgen C Becker
P2860
P2888
P304
P356
10.1007/S00262-013-1434-6
P577
2013-05-11T00:00:00Z
P5875
P6179
1004066632